This NCNA Penny Stock Could Surge Over 300%, Say Analyst NuCana uses a phosphoramidate chemistry technology called ProTide to create a class of drugs that will surmount the limitations of the existing nucleotide analogs behind many chemotherapy drugs. NuCana’s ProTides have already been used in Gilead’s antiviral drug Sovaldi. In May of last year, NuCana...
Looking like a possible buy opportunity. Showing bullish divergence. I'm waiting for the stochastic RSI to cross 20 on the 3 day.
NCNA: NuCana plc 2019-10-25 07:00:05 NuCana Announces FDA Clearance to Commence Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer
waiting for confirmation signe , on 4H frame hammer candle was formed